Yiheng Capital Management, L.P. Beam Therapeutics Inc. Transaction History
Yiheng Capital Management, L.P.
- $1.95 Billion
- Q3 2024
A detailed history of Yiheng Capital Management, L.P. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Yiheng Capital Management, L.P. holds 763,760 shares of BEAM stock, worth $20.5 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
763,760
Previous 845,500
9.67%
Holding current value
$20.5 Million
Previous $19.8 Million
5.54%
% of portfolio
0.96%
Previous 1.6%
Shares
6 transactions
Others Institutions Holding BEAM
# of Institutions
236Shares Held
75.2MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$220 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$211 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$205 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$175 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$130 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.89B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...